Trinity Biotech plc Cash Flow-to-Debt Ratio
Trinity Biotech plc cash flow-to-debt ratio. Trinity Biotech plc (TRIB) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of $-1.55 Million could theoretically repay 0% of its total liabilities ($177.15 Million) in one year. Check Trinity Biotech plc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Trinity Biotech plc (1993–2025)
Cash flow-to-debt ratio of Trinity Biotech plc from 1993 to 2025. Historical debt coverage capacity for Trinity Biotech plc across 33 annual periods. Check Trinity Biotech plc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Trinity Biotech plc Cash Flow-to-Debt Ratio by Year (1993–2025)
Trinity Biotech plc cash flow-to-debt ratio by year from 1993 to 2025. Year-by-year debt coverage analysis for Trinity Biotech plc. For the full cash flow conversion analysis, see cash efficiency ratio of Trinity Biotech plc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.03x | $-5.93 Million | $177.15 Million | ▼ -10.6% |
| 2024 | -0.03x | $-4.19 Million | $138.47 Million | ▲ +78.2% |
| 2023 | -0.14x | $-11.56 Million | $83.38 Million | ▼ -1318.8% |
| 2022 | -0.01x | $-921.00K | $94.28 Million | ▼ -108.8% |
| 2021 | 0.11x | $13.24 Million | $119.21 Million | ▼ -38.0% |
| 2020 | 0.18x | $23.75 Million | $132.62 Million | ▲ +313.5% |
| 2019 | 0.04x | $5.47 Million | $126.36 Million | ▼ -33.0% |
| 2018 | 0.06x | $6.93 Million | $107.18 Million | ▼ -31.9% |
| 2017 | 0.10x | $12.11 Million | $127.42 Million | ▼ -2.8% |
| 2016 | 0.10x | $13.77 Million | $140.87 Million | ▲ +15.0% |
| 2015 | 0.09x | $12.34 Million | $145.07 Million | ▼ -75.2% |
| 2014 | 0.34x | $15.75 Million | $45.87 Million | ▲ +27.6% |
| 2013 | 0.27x | $11.71 Million | $43.48 Million | ▼ -62.4% |
| 2012 | 0.72x | $20.06 Million | $28.03 Million | ▼ -29.5% |
| 2011 | 1.02x | $20.48 Million | $20.17 Million | ▼ -13.8% |
| 2010 | 1.18x | $23.07 Million | $19.59 Million | ▲ +324.6% |
| 2009 | 0.28x | $14.73 Million | $53.10 Million | ▲ +64.5% |
| 2008 | 0.17x | $10.73 Million | $63.60 Million | ▼ -13.0% |
| 2007 | 0.19x | $15.35 Million | $79.13 Million | ▲ +115.5% |
| 2006 | 0.09x | $7.37 Million | $81.87 Million | ▼ -50.2% |
| 2005 | 0.18x | $9.21 Million | $50.98 Million | ▲ +14818.8% |
| 2004 | 0.00x | $42.00K | $34.69 Million | ▼ -98.7% |
| 2003 | 0.10x | $3.60 Million | $37.83 Million | ▼ -78.4% |
| 2002 | 0.44x | $11.65 Million | $26.36 Million | ▲ +79.0% |
| 2001 | 0.25x | $5.06 Million | $20.50 Million | ▼ -0.4% |
| 2000 | 0.25x | $3.02 Million | $12.19 Million | ▲ +44.8% |
| 1999 | 0.17x | $3.82 Million | $22.32 Million | ▲ +620.5% |
| 1998 | -0.03x | $-1.00 Million | $30.40 Million | ▲ +58.9% |
| 1997 | -0.08x | $-1.40 Million | $17.50 Million | ▲ +93.8% |
| 1996 | -1.29x | $-3.60 Million | $2.80 Million | ▼ -173.2% |
| 1995 | -0.47x | $-800.00K | $1.70 Million | ▲ +72.7% |
| 1994 | -1.72x | $-3.10 Million | $1.80 Million | ▼ -29.2% |
| 1993 | -1.33x | $-2.40 Million | $1.80 Million | — |